JP Morgan Chase
LUXAU

JP Morgan Chase’s Lux Health Tech Acquisition Corp. Units LUXAU Stock Holding History

JP Morgan Chase’s Portfolio LUXAU Stock Details LUXAU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-470,000
Closed -$4.72M – 7250
2021
Q4 		$4.72M Buy
470,000
+468,500
+31,233% +$4.77M ﹤0.01% 3104
2021
Q3 		$15K Buy
+1,500
New +$15.3K ﹤0.01% 6107

Other funds holding LUXAU

BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

JP Morgan Chase's LUXAU Position: Q1 2022 in Review

JP Morgan Chase sold out of Lux Health Tech Acquisition Corp. Units (LUXAU) in Q1 2022, closing a stake of 470,000 shares — an estimated $4.72M sold.

JP Morgan Chase first reported a position in LUXAU in Q3 2021 and held it in 2 quarters. The position peaked at $4.72M in Q4 2021. 17 funds tracked by Wall St. Rank hold LUXAU as of Q1 2022.

  • JP Morgan Chase reported no remaining Lux Health Tech Acquisition Corp. Units position as of Q1 2022 after selling out during the quarter.
  • JP Morgan Chase sold 470,000 Lux Health Tech Acquisition Corp. Units shares in Q1 2022, an estimated $4.72M.
  • JP Morgan Chase first reported a position in Lux Health Tech Acquisition Corp. Units in Q3 2021 and held it in 2 quarters.
  • JP Morgan Chase's Lux Health Tech Acquisition Corp. Units position peaked at $4.72M in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Units as of Q1 2022.

Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.